A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers

NCT06008015 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: BR1015
DRUG: BR1015-1
DRUG: BR1015-2

Sponsor

Boryung Pharmaceutical Co., Ltd